Advertisement
Home »

Fenebrutinib Associated With Rapid MS Lesion Reduction

Nov 15, 2023

REFERENCES & ADDITIONAL READING

Bar-Or A, et al. Cerebrospinal fluid and MRI analyses of fenebrutinib treatment in multiple sclerosis reveal brain penetration and early reduction of new lesion activity: results from the phase II FENopta study. O187, MSMilan 2023, 11–13 October, Milan, Italy.

MORE ARTICLES BELOW

PW Weekly Newsletters

The latest articles and insights from your colleagues in your specialty(ies) of choice.


Advertisement
Advertisement
ad
ad
MORE ARTICLES BELOW

PW Weekly Newsletters

The latest articles and insights from your colleagues in your specialty(ies) of choice.

SUBSCRIBE NOW

View all newsletters

RELEVANT ARTICLES FOR YOU

Advertisement